Intervention Review

Depot fluphenazine decanoate and enanthate for schizophrenia

  1. Anthony David1,*,
  2. Clive E Adams2,
  3. Maurice Eisenbruch3,
  4. Seema N Quraishi1,
  5. John Rathbone4

Editorial Group: Cochrane Schizophrenia Group

Published Online: 12 MAY 2010

Assessed as up-to-date: 21 JAN 2004

DOI: 10.1002/14651858.CD000307

Database Title

Additional Information

How to Cite

David A, Adams CE, Eisenbruch M, Quraishi SN, Rathbone J. Depot fluphenazine decanoate and enanthate for schizophrenia. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD000307. DOI: 10.1002/14651858.CD000307.

Author Information

  1. 1

    Institute of Psychiatry, London, UK

  2. 2

    University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

  3. 3

    University of New South Wales, WHO Regional Centre for Health Development, Sydney, Australia

  4. 4

    The University of Sheffield, HEDS, ScHARR, Sheffield, UK

*Anthony David, Institute of Psychiatry, De Crespigny Park, BOX PO68, London, SE5 8AF, UK. a.david@iop.kcl.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 12 MAY 2010

SEARCH

ARTICLE TOOLS

Summary (58K)Standard (807K)Full (1353K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Summary (58K)Standard (807K)Full (1353K)